Drostanolone vs Stanozolol

Drostanolone (B-tier) vs Stanozolol (B-tier). mechanism, trials, evidence boundaries, dosing literature. side-by-side reference.

Drostanolone · tier B

a historical dromostanolone propionate breast-cancer drug with small human oncology series, no valid systemic half-life, and no current approved human product located.

the historical antitumor signal is human evidence, but it is old, small, formulation-specific, and missing the modern PK and safety limbs needed for confidence.

0 modern systemic human PK studies · half-life unknown; no qualifying systemic human or animal plasma half-life for dromostanolone propionate located · androgens

Stanozolol · tier B

Winstrol is stanozolol, an oral or injectable anabolic-androgenic steroid. People seek it for strength and a harder, drier look.

A harder, drier look is plausible, but not proven. Stanozolol does not aromatize, and one four-month trial found no drug-related fluid retention. It also found no anabolic effect, and appearance was not rated. That does not establish dehydration or a guaranteed look.

HDL -33% after 6 weeks of oral stanozolol in an 11-man crossover · half-life no validated human terminal half-life; horse intramuscular suspension apparent terminal half-life 82.1 hours · androgens

at a glance

• Drostanolone: tier B · 0 modern systemic human PK studies
• Stanozolol: tier B · HDL -33% after 6 weeks of oral stanozolol in an 11-man crossover

reptides grades the research record and cites the literature behind every call. research reference only; not medical advice.